Teva Pharmaceutical Industries
TEVA
#660
Rank
NZ$61.29 B
Marketcap
NZ$53.43
Share price
2.83%
Change (1 day)
35.95%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2025 (TTM): NZ$1.06

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is NZ$1.08. In 2024 the company made an earnings per share (EPS) of NZ-$2.48 a decrease over its 2023 EPS that were of NZ-$0.80.

EPS history for Teva Pharmaceutical Industries from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.06-142.87%
2024NZ-$2.48208.51%
2023NZ-$0.80-77.83%
2022NZ-$3.63-657.89%
2021NZ$0.65
2019NZ-$1.57-60.34%
2018NZ-$3.97-85.73%
2017NZ-$27.83-23328.57%
2016NZ$0.12-96.2%
2015NZ$3.15-48.6%
2014NZ$6.13138.67%
2013NZ$2.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.60 1,068.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$6.34 488.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$6.16 470.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$2.94 173.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.00 1,105.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.39 29.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
AstraZeneca
AZN
NZ$5.20 381.75%๐Ÿ‡ฌ๐Ÿ‡ง UK